Literature DB >> 29730154

Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors.

Benjamin Theek1, Maike Baues2, Felix Gremse2, Robert Pola3, Michal Pechar3, Inka Negwer4, Kaloian Koynov4, Benjamin Weber5, Matthias Barz5, Willi Jahnen-Dechent6, Gert Storm7, Fabian Kiessling2, Twan Lammers8.   

Abstract

Tumors are characterized by leaky blood vessels, and by an abnormal and heterogeneous vascular network. These pathophysiological characteristics contribute to the enhanced permeability and retention (EPR) effect, which is one of the key rationales for developing tumor-targeted drug delivery systems. Vessel abnormality and heterogeneity, however, which typically result from excessive pro-angiogenic signaling, can also hinder efficient drug delivery to and into tumors. Using histidine-rich glycoprotein (HRG) knockout and wild type mice, and HRG-overexpressing and normal t241 fibrosarcoma cells, we evaluated the effect of genetically induced and macrophage-mediated vascular normalization on the tumor accumulation and penetration of 10-20 nm-sized polymeric drug carriers based on poly(N-(2-hydroxypropyl)methacrylamide). Multimodal and multiscale optical imaging was employed to show that normalizing the tumor vasculature improves the accumulation of fluorophore-labeled polymers in tumors, and promotes their penetration out of tumor blood vessels deep into the interstitium.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug delivery; EPR; HRG; Nanomedicine; Tumor targeting; Vascular normalization; pHPMA

Mesh:

Substances:

Year:  2018        PMID: 29730154      PMCID: PMC6130770          DOI: 10.1016/j.jconrel.2018.05.002

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  58 in total

Review 1.  To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?

Authors:  F Danhier
Journal:  J Control Release       Date:  2016-11-18       Impact factor: 9.776

Review 2.  Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practice.

Authors:  Christopher G Willett; Sergey V Kozin; Dan G Duda; Emmanuelle di Tomaso; Kevin R Kozak; Yves Boucher; Rakesh K Jain
Journal:  Semin Oncol       Date:  2006-10       Impact factor: 4.929

3.  A nanoparticle size series for in vivo fluorescence imaging.

Authors:  Zoran Popović; Wenhao Liu; Vikash P Chauhan; Jungmin Lee; Cliff Wong; Andrew B Greytak; Numpon Insin; Daniel G Nocera; Dai Fukumura; Rakesh K Jain; Moungi G Bawendi
Journal:  Angew Chem Int Ed Engl       Date:  2010-11-08       Impact factor: 15.336

4.  HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF.

Authors:  Charlotte Rolny; Massimiliano Mazzone; Sònia Tugues; Damya Laoui; Irja Johansson; Cathy Coulon; Mario Leonardo Squadrito; Inmaculada Segura; Xiujuan Li; Ellen Knevels; Sandra Costa; Stefan Vinckier; Tom Dresselaer; Peter Åkerud; Maria De Mol; Henriikka Salomäki; Mia Phillipson; Sabine Wyns; Erik Larsson; Ian Buysschaert; Johan Botling; Uwe Himmelreich; Jo A Van Ginderachter; Michele De Palma; Mieke Dewerchin; Lena Claesson-Welsh; Peter Carmeliet
Journal:  Cancer Cell       Date:  2011-01-06       Impact factor: 31.743

Review 5.  Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.

Authors:  Rakesh K Jain
Journal:  Science       Date:  2005-01-07       Impact factor: 47.728

Review 6.  Lessons from phase III clinical trials on anti-VEGF therapy for cancer.

Authors:  Rakesh K Jain; Dan G Duda; Jeffrey W Clark; Jay S Loeffler
Journal:  Nat Clin Pract Oncol       Date:  2006-01

Review 7.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

8.  Role of vascular normalization in benefit from metronomic chemotherapy.

Authors:  Fotios Mpekris; James W Baish; Triantafyllos Stylianopoulos; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-07       Impact factor: 11.205

9.  Combining two strategies to improve perfusion and drug delivery in solid tumors.

Authors:  Triantafyllos Stylianopoulos; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-28       Impact factor: 11.205

10.  The Theranostic Path to Personalized Nanomedicine.

Authors:  Benjamin Theek; Larissa Y Rizzo; Josef Ehling; Fabian Kiessling; Twan Lammers
Journal:  Clin Transl Imaging       Date:  2014-02-01
View more
  7 in total

Review 1.  Nanomaterial-Based Modulation of Tumor Microenvironments for Enhancing Chemo/Immunotherapy.

Authors:  Quoc-Viet Le; Juhan Suh; Yu-Kyoung Oh
Journal:  AAPS J       Date:  2019-05-17       Impact factor: 4.009

2.  Smart cancer nanomedicine.

Authors:  Roy van der Meel; Einar Sulheim; Yang Shi; Fabian Kiessling; Willem J M Mulder; Twan Lammers
Journal:  Nat Nanotechnol       Date:  2019-11-06       Impact factor: 39.213

3.  Histidine-rich glycoprotein augments natural killer cell function by modulating PD-1 expression via CLEC-1B.

Authors:  Yoshito Nishimura; Hidenori Wake; Kiyoshi Teshigawara; Dengli Wang; Masakiyo Sakaguchi; Fumio Otsuka; Masahiro Nishibori
Journal:  Pharmacol Res Perspect       Date:  2019-05-22

4.  Quartz Crystal Microbalance Measurement of Histidine-Rich Glycoprotein and Stanniocalcin-2 Binding to Each Other and to Inflammatory Cells.

Authors:  Tor Persson Skare; Hiroshi Kaito; Claudia Durall; Teodor Aastrup; Lena Claesson-Welsh
Journal:  Cells       Date:  2022-08-29       Impact factor: 7.666

Review 5.  Fluorescence Imaging as a Tool in Preclinical Evaluation of Polymer-Based Nano-DDS Systems Intended for Cancer Treatment.

Authors:  Tomáš Etrych; Olga Janoušková; Petr Chytil
Journal:  Pharmaceutics       Date:  2019-09-12       Impact factor: 6.321

6.  Multimodal and multiscale optical imaging of nanomedicine delivery across the blood-brain barrier upon sonopermeation.

Authors:  Jan-Niklas May; Susanne K Golombek; Maike Baues; Anshuman Dasgupta; Natascha Drude; Anne Rix; Dirk Rommel; Saskia von Stillfried; Lia Appold; Robert Pola; Michal Pechar; Louis van Bloois; Gert Storm; Alexander J C Kuehne; Felix Gremse; Benjamin Theek; Fabian Kiessling; Twan Lammers
Journal:  Theranostics       Date:  2020-01-12       Impact factor: 11.556

7.  Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy.

Authors:  Fotios Mpekris; Chrysovalantis Voutouri; Myrofora Panagi; James W Baish; Rakesh K Jain; Triantafyllos Stylianopoulos
Journal:  J Control Release       Date:  2022-03-08       Impact factor: 11.467

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.